This inventor holds 2 USPTO granted patents, plus 2 CIPO patents. Top assignee: Bayer Aktiengesellschaft. Active years: 2003-2004.
Company Filing History:
Years Active: 2003-2004
Title: Gudrun Theiss: Innovator in Viral Therapeutics
Introduction
Gudrun Theiss is a prominent inventor based in Germany, recognized for her contributions to the field of viral therapeutics. With a focus on innovative treatments for diseases associated with collagen deposition, her work has the potential to significantly impact medical science.
Latest Patents
Gudrun Theiss holds two notable patents. The first patent, titled "Use Of Strains Of The Parapox Ovis Virus Against Organ Fibrosis," relates to the use of inactivated parapoxviruses for the prophylaxis and treatment of diseases characterized by increased collagen deposition. This invention specifically addresses liver fibrosis and cirrhosis resulting from viral hepatitis and ethanol-induced liver diseases. The second patent, "Use Of Strains Of Parapoxvirus Ovis For Producing Antiviral Medicaments And Medicaments Against Cancer," focuses on the application of parapox ovis virus strains as immune therapeutics for both infectious and non-infectious immune weaknesses. This invention also explores the use of these strains in treating tumor diseases and viral infections.
Career Highlights
Gudrun Theiss is currently associated with Aicuris GmbH & Co. KG, where she continues to advance her research in viral therapeutics. Her innovative approach and dedication to her field have positioned her as a key figure in the development of new medical treatments.
Collaborations
Throughout her career, Gudrun has collaborated with notable colleagues, including Olaf Weber and Tobias Schlapp. These partnerships have fostered a collaborative environment that enhances the research and development of her innovative ideas.
Conclusion
Gudrun Theiss is a trailblazer in the field of viral therapeutics, with significant contributions that hold promise for the treatment of various diseases. Her work exemplifies the impact of innovation in medicine, paving the way for future advancements.